Peggy Kanellou

618 total citations
25 papers, 464 citations indexed

About

Peggy Kanellou is a scholar working on Oncology, Molecular Biology and Hematology. According to data from OpenAlex, Peggy Kanellou has authored 25 papers receiving a total of 464 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 10 papers in Molecular Biology and 9 papers in Hematology. Recurrent topics in Peggy Kanellou's work include Multiple Myeloma Research and Treatments (6 papers), Immunotherapy and Immune Responses (4 papers) and Immunodeficiency and Autoimmune Disorders (3 papers). Peggy Kanellou is often cited by papers focused on Multiple Myeloma Research and Treatments (6 papers), Immunotherapy and Immune Responses (4 papers) and Immunodeficiency and Autoimmune Disorders (3 papers). Peggy Kanellou collaborates with scholars based in Greece, France and United States. Peggy Kanellou's co-authors include Demetrios�� Spandidos, Apostolos Zaravinos, Benjamin Bonavida, Stavroula Baritaki, Stavros Apostolakis, Marie‐Thérèse Dimanche‐Boitrel, Αthanasios Kotsakis, Alexander Stratigos, Odysseas Zoras and Constantina A. Pappa and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Peggy Kanellou

25 papers receiving 453 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peggy Kanellou Greece 12 216 200 92 72 67 25 464
Shogo Shigeta Japan 15 240 1.1× 111 0.6× 130 1.4× 85 1.2× 45 0.7× 50 525
Rebeca Manso Spain 13 342 1.6× 217 1.1× 112 1.2× 39 0.5× 76 1.1× 38 565
Joanne I. Hsu United States 7 346 1.6× 87 0.4× 94 1.0× 34 0.5× 54 0.8× 15 630
Kedar Inamdar United States 15 393 1.8× 253 1.3× 73 0.8× 49 0.7× 141 2.1× 39 772
Neil Kernohan United Kingdom 11 244 1.1× 210 1.1× 60 0.7× 64 0.9× 49 0.7× 22 528
Shruti Bhatt United States 14 261 1.2× 274 1.4× 149 1.6× 64 0.9× 139 2.1× 37 658
Beate Alinger Austria 19 490 2.3× 192 1.0× 152 1.7× 45 0.6× 75 1.1× 23 734
Giuseppe Di Lernia Italy 6 189 0.9× 88 0.4× 79 0.9× 94 1.3× 53 0.8× 6 397
Giulia Orlando Italy 10 322 1.5× 121 0.6× 76 0.8× 34 0.5× 33 0.5× 30 484
Andy Goberdhan United States 5 346 1.6× 202 1.0× 111 1.2× 48 0.7× 21 0.3× 7 535

Countries citing papers authored by Peggy Kanellou

Since Specialization
Citations

This map shows the geographic impact of Peggy Kanellou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peggy Kanellou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peggy Kanellou more than expected).

Fields of papers citing papers by Peggy Kanellou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peggy Kanellou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peggy Kanellou. The network helps show where Peggy Kanellou may publish in the future.

Co-authorship network of co-authors of Peggy Kanellou

This figure shows the co-authorship network connecting the top 25 collaborators of Peggy Kanellou. A scholar is included among the top collaborators of Peggy Kanellou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peggy Kanellou. Peggy Kanellou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kanellou, Peggy, Ilias Georgakopoulos‐Soares, & Apostolos Zaravinos. (2023). Deregulated Gene Expression Profiles and Regulatory Networks in Adult and Pediatric RUNX1/RUNX1T1-Positive AML Patients. Cancers. 15(6). 1795–1795. 3 indexed citations
2.
Kanellou, Peggy, et al.. (2017). Serum Levels of Soluble FLT3 Ligand in Patients with Active Multiple Myeloma Constitute Marker of Bone Marrow Plasma Cell Proliferative Activity. Critical Reviews™ in Oncogenesis. 22(3-4). 255–262. 5 indexed citations
3.
Mavroudi, Irene, Aristides G. Eliopoulos, Charalampos Pontikoglou, et al.. (2017). Immunoglobulin and B-cell disturbances in patients with chronic idiopathic neutropenia. Clinical Immunology. 183. 75–81. 1 indexed citations
4.
Damianaki, Athina, Irene Mavroudi, Helen Koutala, et al.. (2016). Minor populations of paroxysmal nocturnal hemoglobinuria‐type cells in patients with chronic idiopathic neutropenia. European Journal Of Haematology. 97(6). 538–546. 8 indexed citations
5.
Zaravinos, Apostolos, Peggy Kanellou, George Ι. Lambrou, & Demetrios�� Spandidos. (2014). Gene set enrichment analysis of the NF-κB/Snail/YY1/RKIP circuitry in multiple myeloma. Tumor Biology. 35(5). 4987–5005. 14 indexed citations
6.
Tsirakis, George, et al.. (2011). Coexistence of Plasma Cell Dyscrasia with Prefibrotic Stage of Primary Myelofibrosis: A Case Report. PubMed. 2011. 1–3. 1 indexed citations
7.
Pappa, Constantina A., George Tsirakis, Peggy Kanellou, et al.. (2011). Monitoring serum levels ELR+ CXC chemokines and the relationship between microvessel density and angiogenic growth factors in multiple myeloma. Cytokine. 56(3). 616–620. 16 indexed citations
8.
Tsirakis, George, Constantina A. Pappa, Peggy Kanellou, et al.. (2011). Role of platelet‐derived growth factor‐AB in tumour growth and angiogenesis in relation with other angiogenic cytokines in multiple myeloma. Hematological Oncology. 30(3). 131–136. 28 indexed citations
9.
Sfiridaki, Katerina, Constantina A. Pappa, George Tsirakis, et al.. (2011). Angiogenesis-Related Cytokines, RANKL, and Osteoprotegerin in Multiple Myeloma Patients in relation to Clinical Features and Response to Treatment. Mediators of Inflammation. 2011. 1–7. 19 indexed citations
10.
Stylianou, Kostas, Vasiliki Mavroeidi, Ioannis Petrakis, et al.. (2010). Membranous nephropathy and lupus-like syndrome after hematopoietic cell transplantation: a case report. Journal of Medical Case Reports. 4(1). 303–303. 4 indexed citations
11.
Kanellou, Peggy, et al.. (2009). Deregulation of the tumour suppressor genes p14ARF, p15INK4b, p16INK4aand p53 in basal cell carcinoma. British Journal of Dermatology. 160(6). 1215–1221. 25 indexed citations
12.
Zaravinos, Apostolos, Peggy Kanellou, Stavroula Baritaki, Benjamin Bonavida, & Demetrios�� Spandidos. (2009). BRAF and RKIP are significantly decreased in cutaneous squamous cell carcinoma. Cell Cycle. 8(9). 1402–1408. 32 indexed citations
13.
Kanellou, Peggy, Apostolos Zaravinos, Alexander Stratigos, et al.. (2008). Genomic instability, mutations and expression analysis of the tumour suppressor genes p14ARF, p15INK4b, p16INK4a and p53 in actinic keratosis. Cancer Letters. 264(1). 145–161. 59 indexed citations
14.
Apostolaki, Stella, Maria Perraki, Athanasios Pallis, et al.. (2007). Circulating HER2 mRNA-positive cells in the peripheral blood of patients with stage I and II breast cancer after the administration of adjuvant chemotherapy: evaluation of their clinical relevance. Annals of Oncology. 18(5). 851–858. 63 indexed citations
15.
Baritaki, Stavroula, Stavros Apostolakis, Peggy Kanellou, et al.. (2007). Reversal of Tumor Resistance to Apoptotic Stimuli by Alteration of Membrane Fluidity: Therapeutic Implications. Advances in cancer research. 98. 149–190. 72 indexed citations
16.
Kosmatopoulos, K., et al.. (2006). Safety and immunogenicity of the optimized cryptic peptide TERT572Y in patients with advanced cancer : a phase I clinical study. Cancer Research. 66. 334–334. 2 indexed citations
17.
Kanellou, Peggy, et al.. (2006). Role of plasma membrane fluidity alterations in tumor cell sensitization to apoptosis-inducing stimuli: Therapeutic implications. Cancer Research. 66. 298–298. 4 indexed citations
18.
Mavroudis, Dimitriοs, Sébastien Cornet, Peggy Kanellou, et al.. (2006). A Phase I Study of the Optimized Cryptic Peptide TERT<sub>572Y</sub> in Patients with Advanced Malignancies. Oncology. 70(4). 306–314. 47 indexed citations
19.
Xenidis, N., Charalambos Kouroussis, Athanasios Pallis, et al.. (2005). Effect of adjuvant tamoxifen and letrozol on the fate of peripheral blood CK-19 mRNA+ cells in patients with early breast cancer. Journal of Clinical Oncology. 23(16_suppl). 754–754. 3 indexed citations
20.
Kosmatopoulos, K., et al.. (2005). Safety and immunogenicity of the optimized cryptic peptide TERT572Y in patients with advanced malignancies: A Phase I clinical study. Journal of Clinical Oncology. 23(16_suppl). 2579–2579. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shogo Shigeta Breakdown of academic impact, for papers by Rebeca Manso Breakdown of academic impact, for papers by Joanne I. Hsu Breakdown of academic impact, for papers by Kedar Inamdar Breakdown of academic impact, for papers by Neil Kernohan Breakdown of academic impact, for papers by Shruti Bhatt Breakdown of academic impact, for papers by Beate Alinger Breakdown of academic impact, for papers by Giuseppe Di Lernia Breakdown of academic impact, for papers by Giulia Orlando Breakdown of academic impact, for papers by Andy Goberdhan
Rankless by CCL
2026